Abstract:Positron emission tomography (PET) has become a powerful tool for probing biochemical processes in living subjects. PET imaging depends largely on the development of novel PET tracers labeled with positron-emitting radionuclides. Since the four traditional PET isotopes (F-18, C-11, N-13, and O-15) are produced in a cyclotron and are short-lived, their use for long-term observation of biological processes in vivo is limited. In the last decades, extensive research in the development of other unconventional radionuclides (such as Cu-64, Ga-68, Zr-89, Y-86, and I-124) labeled tracers with half-lives complementary to the biological properties of their targeting agents has been conducted. Among these tracers, 86 Y-based PET tracers have gained increasing attention since they are ideal surrogates for in vivo determination of biodistribution and dosimetry of therapeutic Y-90 (pure beta(-)emitter) pharmaceuticals. In this review article, we will brief introduce the physical characteristics, production, and radiochemistry of Y-86, and will summarize the current Y-86-based PET tracers used for molecular imaging and cancer detection in animal studies and in clinical trials.

Pet Tracers Based On Y-86